Latest by Rod McCullom
An HIV vaccine has remained elusive. But a set of new strategies in trials around the world may finally turn that around. Rod McCullom reports.
Vaccines are the most effective means to prevent and even eradicate infectious diseases. Learn the basics of how vaccines work, and the possible routes to a vaccine for HIV.
"History shows us that bacteria will find a way to outlast the antibiotics we're using to treat it. We are running just one step ahead in order to preserve the remaining treatment option,” says Jonathan Mermin of CDC.
PrEP is gaining steam in social media, hook up apps and public health efforts. But one community has been largely absent from this new era of HIV prevention: people who inject drugs. Rod McCullom reports.
Hep C was on the decline in the U.S. But between 2006 and 2012, rates more than tripled across Kentucky, Tennessee, West Virginia and Virginia. Rod McCullom reports on the challenges of an increasingly rural epidemic.
In the week when, 34 years ago, The New York Times reported the first cases of what became known as HIV/AIDS, CDC awarded more than $216 million for five years of prevention efforts. The efforts will focus on gay, bisexual and other men who have se...
The high cost of hepatitis C treatment has inspired lawsuits and protests. Now, activist have targeted the hedge fund investors who they say are reaping profits from the pricey pills. Rod McCullom reports.
As small town and rural opiate use continues to rise, Daniel Raymond of the Harm Reduction Coalition says communities should provide safe disposal rather than lay blame.
A whistleblower lawsuit against the provider of HIV/AIDS care will take time to resolve. However, its filing has brought new attention to AIDS Healthcare Foundation's history, business and media practices and what some have called aggressive tactics....
The first commercial HIV test was approved by the FDA on March 1, 1985. Testing technology and prevention have dramatically improved since that discovery.